Pharmacological Management of Spinal Cord Injuries: Difference between revisions
Jason Feltis (talk | contribs) m (Published a basic shell as per my instructor's request, and inserted a test citation to show I understand how it works. We just completed our first round of reviews and will begin to publish content soon.) |
Jason Feltis (talk | contribs) m (Linked to pages for the particular drugs.) |
||
| Line 2: | Line 2: | ||
This will serve as an introduction.<ref>https://www.nscisc.uab.edu/Public/Facts%20and%20Figures%20-%202018.pdf</ref> | This will serve as an introduction.<ref>https://www.nscisc.uab.edu/Public/Facts%20and%20Figures%20-%202018.pdf</ref> | ||
== Opioids == | == [[Opioids in the Treatment of Spinal Cord Injuries|Opioids]] == | ||
== Benzodiazepines == | == [[Benzodiazepines in the Treatment of Spinal Cord Injuries|Benzodiazepines]] == | ||
== Gabapentin == | == Gabapentin == | ||
== Baclofen == | == [[Baclofen in the Treatment of Spinal Cord Injuries|Baclofen]] == | ||
== [[Corticosteroids - Treatment of Spinal Cord Injuries|Corticosteroids]] == | |||
== Overall Implications for Physical Therapy == | == Overall Implications for Physical Therapy == | ||
__INDEX__ | __INDEX__ | ||
<references /> | |||
Revision as of 19:38, 13 November 2018
Introduction[edit | edit source]
This will serve as an introduction.[1]
